Positive Affect Promotion to Empower Optimal Adherence to HIV Therapy
Completed · Phase 1
Conditions studied: HIV/AIDS
In brief
This study assesses the feasibility and acceptability of the APPEAL program, a 3-session intervention designed to promote positive affect among men and women living with HIV infection. Forty participants will be randomly assigned to receive the APPEAL program, and another 40 will receive standard of care. All participants will complete self-reported assessments at baseline and at 3 and 6 months, and will have their HIV antiretroviral medication adherence monitored as part of study participation.
Key facts
- Study ID
- NCT04035759
- Run by
- State University of New York - Downstate Medical Center
- People needed
- 20
- Starts
- 2019-10-16
- Expected to finish
- 2021-04-26
- Last updated by the study team
- 2021-11-01
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Receiving HIV care at site of recruitment
- Prescribed an HIV antiretroviral regimen
- HIV RNA viral load less than 200 copies/mL in last six months
You may not qualify if…
- Unable to communicate in English
- Prior participation in formative components of the study
- Plans to move outside of New York City in next six months
- Has cognitive impairment that would limit ability to provide informed consent
Where it is running
- SUNY Downstate Health Sciences University — Brooklyn, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.